openPR Logo
Press release

Asia Pacific is the fastest growing Single Nucleotide Polymorphism (SNP) Genotyping Market due to the rising demand of SNP genotyping in emerging economies by 2023

02-13-2019 04:25 PM CET | Health & Medicine

Press release from: Allied Market Research

Asia Pacific is the fastest growing Single Nucleotide

Single Nucleotide Polymorphism (SNP) is usually a mutation found at a specific locus or a single base pair mutation containing two alleles. SNPs aid in understanding the correlations among genotype and behavior indicated by all living organisms. SNP genotyping is the measurement of genetic variations that commonly occur in individuals. Unlike conventional time consuming, expensive and labor extensive detection technology, SNP technology is highly efficient, relatively inexpensive and automated.

Get the Sample Report: https://www.alliedmarketresearch.com/request-toc-and-sample/1464?utm_source=openpr&utm_medium=Niranjan

Analysis of SNPs is widely utilized in different disciplines of genetics and related studies, commonly associated with studying genetic determinants of many complex diseases. SNP technologies are extensively utilized for detection and are beneficial in the etiology of several human diseases such as cancer, cardiovascular, Alzheimers, Asthma, and others.

In addition, SNPs are essential markers in various human ailments and are intensely employed in pharmacogenomics to customize personalized medicine in a better way. Therefore, rising applications of SNPs in several Life Sciences & Biotechnology aspects are driving the Single Nucleotide Polymorphism (SNP) genotyping market.

Furthermore, emerging technologies of SNP genotyping in the Life Sciences field such as Agricultural biotechnology, diagnostic research, pharmaceuticals, pharmacogenomics, and animal & livestock breeding is expected to boost the market growth in the future. Other key factors driving the market are the rising prevalence of diabetes, cardiovascular diseases, and cancer. However, insufficient reimbursement policies limit the growth of SNPs genotyping market.

For Purchase Inquiry: https://www.alliedmarketresearch.com/purchase-enquiry/1464?utm_source=openpr&utm_medium=Niranjan

The Global Single Nucleotide Polymorphism (SNP) genotyping market is segmented on the basis of technologies, applications, and geography. Based on the technologies, the market is segmented into SNP Genechips and Microarrays, TaqMan Assay (Allele-Specific Hybridization), SNP, genotyping based upon Pyrosequencing, SN Plex based upon Applied Biosystems, Sequenom Masarray MALDI-TOF, RFLP (Restricted Fragment Length Polymorphism), SSCP (Single-Strand Conformation Polymorphism), ARMS (Amplification Refractory Mutation System) and Other SNP genotyping technologies. There are several application of SNPs that include Animal genetics, Plant improvement, Diagnostic research, Aquaculture, Pharmaceuticals and Pharmacogenomics, Agricultural Biotechnology, Animal Livestock and breeding, and Other SNP applications.

Amongst all the applications, pharmacogenomics and diagnostics are the most attractive application in this market. Geographically, the report is segmented across four regions namely North America, Europe, Asia Pacific, and LAMEA. North America is the dominating region in Single Nucleotide Polymorphism (SNP) genotyping market due to growing commercial research in personalized medicines, animal breeding, and others. In addition, Asia Pacific is the fastest growing market due to the rising demand for SNP genotyping in emerging economies such as China and India across different fields, which largely propel market growth.

Key strategies adopted by major players in this market include product launches, collaborations, and agreements. Recently, on April 13, 2015, Affymetrix Inc., collaborated with MTI Ltd. for personal genomics and genetic research services in Japan to expand their business in healthcare. Companies profiled in this report include Beckman Coulter, Bio-Rad Laboratories, GE Healthcare, Affymetrix Inc., Sequenom, Inc., Roche Holding AG, Qiagen, Fluidigm Corporation, Agilent Technologies, Thermo Fisher Scientific Inc., and few others

KEY MARKET BENEFITS:
• Comprehensive analysis of factors that drive and restrict the growth of the Global Single Nucleotide Polymorphism (SNP) genotyping market is provided. For instance, the growing demand of SNPs in the drug development process will drive the market; however, insufficient reimbursement policies are likely to be a major restraint of the market.
• The projections in this report are made by analyzing the current market trends and the market potential for the forecast period of 2014-2020, in terms of value.
• A comprehensive analysis of technologies, applications and geography segments enables the identification of growth opportunities within the Global Single Nucleotide Polymorphism (SNP) genotyping market.
• Competitive intelligence (of leading manufacturers of Single Nucleotide Polymorphism (SNP) genotyping) helps in understanding the competitive scenario across geographies.
• A SWOT analysis of the key market players is provided to illustrate the business strategies adopted by the companies.
• The report provides a quantitative analysis of the current market and estimations through 2014-2020 that help in identifying the prevailing market opportunities to capitalize on.
• Comprehensive analysis of all geographic regions is provided which helps in determining the prevailing opportunities across these geographies.

KEY MARKET SEGMENTS:

The Global Single Nucleotide Polymorphism (SNP) genotyping market is segmented into technology, application and geography segments.

Single Nucleotide Polymorphism (SNP) genotyping By Technology
• SNP Genechips and Microarrays
• TaqMan Assay (Allelle-Specific Hybridization)
• SNP genotyping based upon Pyrosequencing
• SN Plex based upon Applied Biosystems
• Sequenom Masarray MALDI-TOF
• RFLP (Restricted Fragment Length Polymorphism)
• SSCP (Single-Strand Conformation Polymorphism)
• ARMS (Amplication Refractory Mutation System)
• Other SNP genotyping technologies

Single Nucleotide Polymorphism (SNP) genotyping By Application
• Animal genetics
• Plant improvement
• Diagnostic research
• Aquaculture
• Pharmaceuticals and Pharmacogenomics
• Agricultural Biotechnology
• Animal Livestock and breeding
• Other SNP applications

Single Nucleotide Polymorphism (SNP) genotyping By Geography
• North America
• Europe
• Asia Pacific
• LAMEA

About Us:-

Allied Market Research (AMR) is a full-service market research and business consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact Us:-

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Asia Pacific is the fastest growing Single Nucleotide Polymorphism (SNP) Genotyping Market due to the rising demand of SNP genotyping in emerging economies by 2023 here

News-ID: 1585997 • Views: 529

More Releases from Allied Market Research

North America Geogrid Market 2020 Segmentation, Demand, Growth, Trend, Opportuni …
According to the report published by Allied Market Research, the North America geogrid market generated $282.0 million in 2019, and is estimated to reach $408.25 million by 2027, registering a CAGR of 7.0% from 2020 to 2027. The report offers an extensive analysis of changing market dynamics, key winning strategies, business performance, major segments, and competitive scenarios. Surge in infrastructure development activities across the U.S. and Mexico and superior physical properties
Intravenous Immunoglobulin (IVIG) Market 2020 In-Depth Analysis of Industry Shar …
Global intravenous immunoglobulin market accounted for $8,995 million in 2017, and is projected to reach $15,964 million by 2025, registering a CAGR of 7.5% from 2018 to 2025. Immunoglobulin (Ig) is a plasma-derived product, which is obtained from the serum of healthy donors. The isolated plasma product is clinically treated and purified to Ig, which can be further used in the treatment of patients with antibody deficiency. Intravenous immunoglobulin (IVIG) finds
Asthma and COPD Drugs Market Is Expected to Witness a Steady Growth by 2026
"Asthma and COPD Drugs Market by Disease and Medication Class - Global Opportunity Analysis and Industry Forecasts, 2014-2022", projects that the global market for Asthma and COPD Drugs was valued at $38,960 million in 2015 and would reach $50,359 million by 2022, registering a CAGR of 3.7% from 2016 to 2022. Asthma segment dominated the market in 2015 and expected to continue its dominance throughout the forecast period. North America
Synthetic Biology Market in Global Industry by Top Companies, Type and Applicati …
Global Synthetic biology market is forecast to reach $38.7 billion by 2020, at a CAGR of 44.2% during the forecast period (2014 - 2020). Europe occupies largest share in the global market and would hold-on to its position throughout 2020. However, Asia Pacific is the fastest growing market with a CAGR of 46.4% from 2014 - 2020. Read Full Report @ https://www.alliedmarketresearch.com/synthetic-biology-market Synthetic biology is at a nascent stage and has recently

All 5 Releases


More Releases for SNP

Polyvinyl Alcohol (PVA) Market Forecast 2018 - 2028 | KURARAY, Polysciences, Pol …
Polyvinyl Alcohol (PVA) Market: Overview Polyvinyl alcohol (PVA), is a synthetic polymer which is soluble in water. It is an important compound utilized in making process in several end-use sectors. The major end-use sectors are construction, food packaging, electronics, printing, coatings, textile, paper, and cosmetics. PVA compound is majorly boosted by the rising demand from the food packaging sector, as it providea more solubility in water is a material with better
Global SNP Genotyping Market 2018-2025 Demand and Insights Analysis Report
Complete report on SNP Genotyping market spread across 116 pages, profiling 06 companies and supported with 178 tables and figures is now available at: https://www.inforgrowth.com/requestdiscount/r/32439/global-snp-genotyping-and-analysis-market-insi Single Nucleotide Polymorphisms (SNPs) are the most common genetic variation in people. It is a single base pair mutation, usually found at a specific locus. Analysis of SNPs is generally used to study the genetic determinants associated with diseases. SNP genotyping has a wide
Single Nucleotide Polymorphism (SNP) Genotyping Market Revenue, Opportunity, For …
Single Nucleotide Polymorphism (SNP) Genotyping are single base positions in the genome that shows natural variation within a population. Single Nucleotide Polymorphism (SNP) Genotyping is the most profuse form of genetic variation in the human beings, totaling to all most 90% of all the differences between distinct individuals. Single Nucleotide Polymorphism (SNP) Genotyping patterns are most likely to affect many human phenotypes. Single Nucleotide Polymorphism (SNP) Genotyping plays a crucial
SNP Genotyping Market 2018 SWOT Analysis by Players: Illumina, Affymetrix, Appli …
Global SNP Genotyping Market Size, Status and Forecast 2025 presents an in-depth assessment of the SNP Genotyping industry including enabling technologies, deployment models, market drivers, key trends, standardization, regulatory landscape, challenges, operator case studies, opportunities, future roadmap, value chain, ecosystem player profiles and strategies. The report also presents forecasts for SNP Genotyping Market investments from 2018 till 2025. This report divides the global SNP Genotyping market on the basis of types
Single Nucleotide Polymorphism (SNP) Genotyping Market Size, Status and Forecast …
The Single Nucleotide Polymorphism (SNP) Genotyping market was valued at 7620 million US$ and it is expected to reach 35200 million US$ by the end of 2025, at a CAGR of 21.1% during the forecast period. Many countries are focusing on innovations, and expansions are being carried out through rural electrification projects, which would help increase the demand for Single Nucleotide Polymorphism (SNP) Genotyping in the coming years. This research report
SNP Genotyping and Analysis Market: Challenges and Opportunities Report 2019
The falling prices of sequencing have fanned research and development in SNP genotyping and analysis. Moreover, an increasing demand for breeding livestock will prove conducive to the growth of the global SNP genotyping and analysis market, says TMR in a new market research report. According to the report, titled, ‘SNP Genotyping and Analysis Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019,’ the market will